Sharpe Amanda L, Liter Laci R, Donohue Darius, Carter Kelsey A, Vangeneugden Patricia, Weaver Sofia, Stout Michael B, Beckstead Michael J
Department of Pharmaceutical Sciences, University of Oklahoma Health Sciences.
Aging and Metabolism Research Program, Oklahoma Medical Research Foundation; Graduate Program in Biomedical Sciences, University of Oklahoma Health Sciences.
bioRxiv. 2024 Sep 7:2024.09.03.611052. doi: 10.1101/2024.09.03.611052.
Although opioid abuse is more prevalent in young individuals, opioid use, overdose, and use disorders continue to climb at a rapid rate among the elderly. Little is known about abuse potential in a healthy aged population, in part due to technical and logistical difficulties testing intravenous self-administration in aged rodents. The goal of this study was to address the critical gap in the literature regarding age-dependent differences in opioid (remifentanil and fentanyl) self-administration between old and young mice. Male and female mice were grouped into young (mean: 19 weeks) and old (mean: 101 weeks), and were trained to self-administer intravenous fentanyl or remifentanil in daily sessions. In both old and young mice, acquisition, intake, and cue-responding after forced abstinence were measured for both drugs, and a dose-response curve (remifentanil) and dose-escalation (fentanyl) were conducted. Surprisingly, old mice learned to self-administer both remifentanil and fentanyl faster and more accurately than young mice. Baseline intake of remifentanil was also substantially greater in old mice compared to their young counterparts; however, we did not see increased intake of fentanyl with age at either dose tested. Further, compared to young mice, the old mice showed a greater incubation of responding for cues previously associated with remifentanil after a forced abstinence, but again this was not observed with fentanyl. Together these data suggest that an aged population may have an increased drug-abuse vulnerability for opioids compared to young counterparts and underscore the importance of future work on mechanisms responsible for this increased vulnerability.
尽管阿片类药物滥用在年轻人中更为普遍,但阿片类药物的使用、过量使用及使用障碍在老年人中仍在快速攀升。对于健康老年人群中的滥用可能性知之甚少,部分原因是在老年啮齿动物中测试静脉自我给药存在技术和后勤方面的困难。本研究的目的是填补文献中关于老年和年轻小鼠在阿片类药物(瑞芬太尼和芬太尼)自我给药方面年龄依赖性差异的关键空白。将雄性和雌性小鼠分为年轻组(平均:19周)和老年组(平均:101周),并训练它们在每日实验中自我静脉注射芬太尼或瑞芬太尼。对于老年和年轻小鼠,均测量了两种药物在强制戒断后的习得、摄入量及线索反应,并绘制了剂量反应曲线(瑞芬太尼)和剂量递增曲线(芬太尼)。令人惊讶的是,老年小鼠比年轻小鼠更快且更准确地学会了自我注射瑞芬太尼和芬太尼。与年轻小鼠相比,老年小鼠瑞芬太尼的基线摄入量也显著更高;然而,在所测试的两种剂量下,我们均未发现芬太尼的摄入量随年龄增加。此外,与年轻小鼠相比,老年小鼠在强制戒断后对先前与瑞芬太尼相关的线索的反应潜伏期更长,但芬太尼未出现这种情况。这些数据共同表明,与年轻人群相比,老年人群可能对阿片类药物的药物滥用易感性更高,并强调了未来研究导致这种易感性增加的机制的重要性。